My Account Log in

2 options

Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer.

Online

Available online

View online

U.S. Government Documents Available online

View online
Format:
Book
Government document
Contributor:
United States. Agency for Health Care Policy and Research
Blue Cross and Blue Shield Association. Technology Evaluation Center
Series:
Evidence report/technology assessment. Summary ; no. 4.
AHCPR pub. ; no. 99-E 011.
Evidence report/technology assessment. Summary ; no. 4
AHCPR publication ; no. 99-E011
Language:
English
Subjects (All):
Prostate--Cancer--Hormone therapy.
Prostate.
Antiandrogens--Therapeutic use.
Antiandrogens.
Cost effectiveness.
Outcome assessment (Medical care).
Androgen Antagonists--therapeutic use.
Cost-Benefit Analysis.
Gonadotropin-Releasing Hormone--antagonists & inhibitors.
Outcome Assessment, Health Care.
Prostatic Neoplasms--drug therapy.
Randomized Controlled Trials as Topic.
Outcome and Process Assessment, Health Care.
Treatment Outcome.
cost benefit analysis.
Medical Subjects:
Androgen Antagonists--therapeutic use.
Cost-Benefit Analysis.
Gonadotropin-Releasing Hormone--antagonists & inhibitors.
Outcome Assessment, Health Care.
Prostatic Neoplasms--drug therapy.
Randomized Controlled Trials as Topic.
Outcome and Process Assessment, Health Care.
Treatment Outcome.
Physical Description:
1 online resource.
Place of Publication:
[Rockville, Md.] : [U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research], [1999]
Notes:
Title from title screen (viewed on Apr. 29, 2004).
"January 1999."
"The full evidence report from which this summary was taken was prepared by the Evaluation Technology Center, an AHCPR Evidence-based Practice Center of the Blue Cross and Blue Shield Association, Chicago, Illinois, under contract no. 290-97-0015."
Other Format:
Relative effectiveness and cost-effectiveness of methods of andogen suppression in the treatment of advanced prostatic cancer
OCLC:
41321493

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account